In 2013, The Campbell Foundation provided an $86,431 grant to a team of researchers at the University of California Davis to develop a gene therapy strategy designed to generate an HIV-resistant immune system in patients. Joseph Anderson, principal investigator of the study and assistant professor of internal medicine at UC Davis, along with his team, modified human stem cells with genes that resist HIV infection. They then transplanted a near-purified population of these cel